really good presentation, lots of new data points, very considerate and enlightening for shareholders regarding the platform technology as a whole; key takeaway that market focus on PYC values derived from individual leads, such as VP-001, will diminish in 2022 as new leads come to the fore - demonstrating potency of PYC tech.
regarding CNS - Rohan mentioned ALS is of interest (am very excited that PYC is tackling this) - and activity aligns with the discovery team hiring a:
Scientific Research Assistant - Histology
https://www.seek.com.au/RNA-jobs/in-Perth-CBD,-Inner-&-Western-Suburbs-Perth-WA
Ann: 2021 AGM Chairman's Address and CEO Presentation, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |